My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Ram Mukunda

Recent news which mentions Ram Mukunda

Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial
Tickers IGC NEWS
Tags IGC/AD1 Alzheimer's cannabinoid/based drug Health Care
From Benzinga
EXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success
Tickers DRUG IGC
Tags Top Stories IGC Market News
From Benzinga
IGC Pharma Announces Q3 2024 Earnings: Strategic Patent Achievements Propel Forward Amid Losses
Tickers IGC
Tags Ram Mukunda IGC Biotech
From Benzinga
Cannabis Based Pain Relief Solution Receives European Patent Approval
Tickers IGC
Tags pharma News IGC
From Benzinga
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
Tickers POTX TOKE
Tags TOKE Cannabis Benzinga
From Benzinga
IGC Pharma FY23 Revenue Grows 129%, What About Net Loss?
Tickers IGC
Tags Ram Mukunda Markets Cannabis
From Benzinga
IGC Q3 2023 Revenue Grows 133% YoY, What About Net Loss?
Tickers IGC
Tags Earnings News IGC
From Benzinga
IGC Expanding Clinical Trials Of THC Based Drug Following Approval From Health Canada
Tickers IGC
Tags Ram Mukunda Markets Cannabis
From Benzinga
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
Tickers IGC
Tags premium Market News IGC
From Benzinga
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials
Tickers IGC
Tags IGC News Earnings
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.